On Friday, NXP Semiconductors NV (NASDAQ:NXPI)’s shares declined -0.84% to $103.81.
NXP Semiconductors NV (NXPI) declared the pricing of the formerly declared offering by its auxiliaries NXP B.V. and NXP Funding LLC of USD 600 million aggregate principal amount of senior unsecured notes due 2020 (the “2020 Notes”) and USD 400 million aggregate principal amount of senior unsecured notes due 2022 (the “2022 Notes”, together with the 2020 Notes, the “Notes”) following Rule 144A and Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”). The Notes will be fully and unconditionally guaranteed, jointly and severally, on a senior basis by certain of NXP’s wholly-owned auxiliaries located in the Netherlands and the United States (the “Notes Guarantees”) and will be structurally subordinated to the liabilities, counting trade payables, of NXP’s auxiliaries that have not guaranteed the Notes. In addition, the Notes will be effectively subordinated to all secured debt of the issuers and the guarantors, to the extent of the value of the assets securing such debt.
The 2020 Notes will bear interest at 4.125% per annum and will mature on June 15, 2020. The 2022 Notes will bear interest at 4.625% per annum and will mature on June 15, 2022. Interest on the Notes will be payable semi-annually on December 15 and June 15 of each year, starting on December 15, 2015.
NXP Semiconductors N.V., a semiconductor company, provides high performance mixed signal and standard product solutions for radio frequency (RF), analog, power administration, interface, security, and digital processing products worldwide. It provides in-vehicle networking, car passive keyless entry and immobilization, and car radio and audio amplifiers; car solid state lighting drivers; communication products that are related to assisted and autonomous driving; ICs for e-government, transportation, and access administration; RF power amplifiers, small signal RF discretes, and RF ICs for mobile, consumer electronics, and cable television infrastructure; AC-DC power conversion ICs for notebook personal computers; low power audio ICs; and microcontrollers.
SolarCity Corp (NASDAQ:SCTY)’s shares dropped -0.51% to $55.17.
SolarCity Corp (SCTY) America’s #1 solar power provider, will make it possible for many Rhode Island homeowners to install solar with no upfront cost and pay as much as 20 percent less by going solar than they pay the utility. SolarCIty is making its popular MyPower solar loan accessible in Rhode Island for the first time. SolarCity anticipates the unique solar loan to right away become the most affordable residential solar power option in the state.
MyPower loan payments are based on the production of the solar energy system, just like a solar power purchase agreement (PPA). Unlike a PPA, the homeowner retains ownership of the solar panels. SolarCity’s affordable solar power options have made it the number one choice among American consumers—the company is presently providing one out of every three new solar energy systems in the U.S.
Initially, homeowners in ten towns in the National Grid territory will have access to SolarCity’s services: Coventry, Cranston, Cumberland, East Providence, Johnston, North Providence, South Kingstown, Warwick, West Warwick and Woonsocket. Residents outside of the initial service area can sign up to be alerted as soon as service is accessible to their homes. Rhode Island is the 18th state where SolarCity offers service and the fourth in New England, joining Connecticut, Massachusetts and New Hampshire.
SolarCity Corporation designs, manufactures, installs, maintains, monitors, leases, and sells solar energy systems to residential, commercial, government, and other customers in the United States. It offers solar energy systems; solar lease and power purchase agreement finance products; mounting hardware for photovoltaic panels; and related software, in addition to develops a proprietary battery administration system, which is designed to enable remote, bidirectional control of distributed energy storage that can provide benefits to customers, utilities, and grid operators.
At the end of Friday’s trade, Sabre Corp (NASDAQ:SABR)‘s shares dipped -1.74% to $24.32.
Sabre Corp (SABR) has signed a new technology agreement with Turkey’s leading passenger air carrier, Turkish Airlines, to provide its AirCentre Flight Plan Manager solution to streamline the airline’s operations. In addition, the airline will be moving from its current flight tracking system to adopt Sabre’s Flight Explorer within the scope of this agreement.
Since the start of this agreement, Sabre has worked closely with Turkish Airlines to implement AirCentre Flight Plan Manager to provide vital cost savings and support key flight planning decisions. Under the new agreement, the solution will provide a noteworthy support for strengthening the flag carrier’s position within the regions it serves.
Sabre Corporation provides technology solutions to the travel and tourism industry worldwide. It operates in two segments: Travel Network, and Airline and Hospitality Solutions. The Travel Network segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, counting airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators, with a network of travel buyers comprising online and offline travel agencies, travel administration companies, and corporate travel departments. The Airline Hospitality Solutions segment offers a portfolio of software technology products and solutions through software-as-a-service and hosted delivery models to airlines, hotel properties, and other travel suppliers.
Cardinal Health Inc (NYSE:CAH), ended its Friday’s trading session with -0.88% loss, and closed at $88.88.
Cardinal Health Inc (CAH) declared plans to acquire The Harvard Drug Group (THDG), a distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers. THDG is presently owned by Court Square Capital Partners. Cardinal Health will pay $1.115 billion using existing cash and new debt. The transaction is predictable to close in the starting of fiscal year 2016 subject to regulatory approvals and other customary closing conditions.
Assuming this timing, Cardinal Health anticipates accretion in non-GAAP diluted earnings per share (EPS) from ongoing operations of greater than $0.15 per share in fiscal 2016, net of the $0.03 to $0.04 per share of interest expense for the related debt financing. Cardinal Health anticipates accretion in non-GAAP diluted EPS of more than $0.20 in fiscal 2017 and for accretion to be increasingly greater thereafter.
Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
